PHarmaceutical tech@2x
  • News

    Most Read

    • CDSCO panel recommends approval for trial of Bharat Biotech’s nasal vaccine
    • Syntegra collaborates with US NIH to increase access to Covid-19 data
    • Aruvant partners with Lonza to manufacture sickle cell disease treatment

    Most Recent

    Clinical Trials

    CDSCO panel recommends approval for trial of Bharat Biotech’s nasal vaccine

    20 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Canada looks to enhance its talent pool post Covid – leading macroeconomic influencers
    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
    • Biden’s stimulus plan focuses on vaccine, state and local support – leading macroeconomic influencers

    Most Recent

    Canada looks to enhance its talent pool post Covid – leading macroeconomic influencers

    20 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • Canada looks to enhance its talent pool post Covid – leading macroeconomic influencers
    • International update: US Covid deaths exceed 400,000 – global infections pass 96.1 million
    • Coronavirus company news summary – Iraq authorises AstraZeneca/University of Oxford and Sinopharma’s vaccines – Russia reports its second Covid-19 vaccine is 1000.000000e+0ffective in Phase I and II studies

    Most Recent

    Canada looks to enhance its talent pool post Covid – leading macroeconomic influencers

    20 Jan 2021
  • Themes
  • Deals

    Most Read

    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
    • Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m
    • NewAmsterdam Pharma raises $196m through Series A funding round

    Most Recent

    Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

    19 Jan 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • RSD
    • Kiskun Meridian
    • Baxter BioPharma Solutions

    Most Recent

    RSD

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

AstraZeneca divests Atacand’s European rights for $210m

AstraZeneca has signed an agreement to sell the European commercial rights for its Atacand (candesartan...

26 July 2018

Latest News

Clinical Trials

Gritstone, NIAID enter clinical trial agreement for next-gen Covid-19 vaccine

20 Jan 2021
Oncology

Lilly and Merus partner to develop T-Cell re-directing antibody therapies

20 Jan 2021
Clinical Trials

CDSCO panel recommends approval for trial of Bharat Biotech’s nasal vaccine

20 Jan 2021
AI

Syntegra collaborates with US NIH to increase access to Covid-19 data

19 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more